Food and Drug Administration (FDA)
Medetomidine Infiltrates the US Illicit Opioid Market
Notes from the Field: Cluster of Severe Illness from Neptune’s Fix Tianeptine Linked to Synthetic Cannabinoids — New Jersey, June–November 2023
Meeting National Safety Council Recommendations: Accurate Rapid Tests and Laboratory Confirmation Procedures for Fentanyl and Prevalent Opioids in Oral Fluid
Quantification of hordenine in a complex plant matrix by direct analysis in real time-high-resolution mass spectrometry: Application to the "plant of concern" Sceletium tortuosum
Direct Analysis in Real Time Mass Spectrometry (DART-MS) for Seized Drug Analysis
Labeling with Love or Lethal Consequences for CBD Containing Products
Ethanol Concentration in 56 Refillable Electronic Cigarettes Liquid Formulations Determined by Headspace Gas Chromatography With Flame Ionization Detector (HS-GC-FID)
Development of Matrix Matched Quality Control Materials and Sample Preparation Techniques for the Analysis of Marijuana Infused Products and their Application to Edible Testing
The Importance of Data to the MDI Community and Stakeholders
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes
Just Science Podcast: Just Analyzing Beverages for Cannabinoids
What You Can't Buy, Can't Kill You
Development of Matrix Matched Quality Control Materials and Sample Preparation Techniques for the Analysis of Marijuana Infused Products and their Application to Edible Testing
Exemption Request Information
While an exemption request may not be the most expeditious way to meet the requirements of this rule, the regulation for Protection of Human Subjects, 28 CFR Part 46 §46.101(b)(1)-(6), defines categories of research involving human subjects that are exempt from its provisions. It is important to note that these exemptions do not apply to studies involving incarcerated persons, fetuses, pregnant women, or human in...